Month: May 2021

Enlarge (credit: Getty Images)

Enabling two-factor authentication (2FA) on a Google account requires someone who is proactive about account security. Users have to log in, dig through the settings, and tick the right boxes. Of the billions of Google accounts out there, the uptake on 2FA is probably not that high, and Google is tired of it.

Yesterday, for "World Password Day," Google announced a very bold move for account security. "Soon," the company says, it will start "automatically enrolling" users in 2FA, provided their accounts are appropriately configured. Google doesn't go into detail about what "appropriately configured" means, but it sounds like anyone who can have 2FA enabled will have 2FA enabled soon. Google's preferred 2FA method is the "Google Prompt," a notification Google pushes to your phone when you're attempting to sign in. Rather than requiring you to type in a clunky code, the Google Prompt provides a simple "yes/no" check, making 2FA easier than ever.

On Android, Google Prompt is a full-screen pop-up built into every device as part of Google Play Services, so that's easy. On iOS, Google Prompt requests for your account can be received by the Google Search app, the Gmail app, or the dedicated Google Smart Lock app. It sounds like everyone meeting these requirements will soon be enrolled in 2FA.

Enlarge (credit: Getty | YinYang)

Pharmaceutical companies spend around $6.5 billion a year on advertising, and even though Facebook prohibits the use of “sensitive health information” in ad targeting, about $1 billion of that ad spending ends up in the companies' pockets. Big Pharma, it turns out, has found some creative ways to work within Facebook’s rules.

Facebook’s ad targeting allows drug companies to zero-in on likely patients by aiming not for their conditions but for Facebook-defined interests that are adjacent to their illnesses, according to a report by The Markup. The site used a custom web browser to analyze what ads Facebook served to 1,200 people and why, and it found that Big Pharma frequently used illness “awareness” as a proxy for more sensitive health information.

The range of treatments advertised to potential patients ran the gamut. Novartis used “National Breast Cancer Awareness Month” to sell Facebook users on Piqray, a breast cancer pill that lists for $15,500 for a 28-day supply. AstraZeneca ran ads for Brilinta, a $405-per-month blood thinner, based on whether Facebook thought a user was interested in “stroke awareness.” And GlaxoSmithKline shows ads for Trelegy, a $600-per-month inhaler, if someone was flagged by Facebook for “chronic obstructive pulmonary disease [COPD] awareness.”

The bones of a pygmy mammoth. (credit: National Park Service/Justin Tweet)

Humans haven't always been great to nature. But at least our ancestors may not have killed off island megafauna in the distant past, so that's something. New research, published in the Proceedings of the Natural Academy of Sciences, suggests that there's not enough data to say that hominids in the Pleistocene—2.6 million to 11,700 years ago—were responsible for most of the extinctions on the islands they traveled to.

Overkill

The hypothesis that homo sapiens' distant ancestors killed off the world’s myriad ancient megafauna (not just on islands) dates back to 1966, with geoscientist Paul Martin's "overkill" proposal. But the idea has been floating around for far longer than the formal proposal. According to Julien Louys—associate professor of paleontology at Griffiths University in Australia and an author of the new research—the question of what caused the death of the world's megafauna dates back to the 19th century.

“It has, in certain circles, become very polarized,” Louys told Ars.